• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
All
Options & Futures
Funds
IPO Subscription
Structured Products
Investment Wiki
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List

Kezar Life Sciences(KZR.US)

Overview
News
Financials
© 2026 Longbridge|Disclaimer

Event Tracking

Nov13
Kezar Life Sciences released FY2025 9 Months earnings on November 12, 2025 (EST), actual revenue USD 0, actual EPS USD -5.6737
04:00
Kezar Life Sciences released FY2025 Q3 earnings on November 12, 2025 (EST), with actual revenue of USD 0 (forecast USD 0) and actual EPS of USD -1.533 (forecast USD -1.9475)
04:00
Nov7
Kezar Life Sciences Announces Positive Results from Phase 2 Clinical Trials of Zetomipzomib
12:03
Oct17
Phipps covers healthcare sector and focuses on related stocks
08:31
Aug14
Kezar Life Sciences released FY2025 Semi-Annual earnings on August 13 (EST) with actual revenue of USD 0 and EPS of USD -4.1404
03:00
Kezar Life Sciences released FY2025 Q2 earnings on August 13 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -1.8744 (forecast USD -2.2866)
03:00

Schedules & Filings

Schedules
Filings
Nov12
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -11.23 M, EPS -1.533

Aug13
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -13.7 M, EPS -1.8744

May13
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -16.56 M, EPS -2.2661

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
FLYX
7.230
+130.25%
+4.090
CGTL
2.530
+118.10%
+1.370
PAPL
2.240
+56.64%
+0.810
ELVN
23.250
+50.29%
+7.780
UAVS
1.740
+45.00%
+0.540
MRNO
1.520
+43.40%
+0.460
ACON
8.170
+42.09%
+2.420
IPSC
1.770
+36.15%
+0.470
NVVE
4.710
+34.19%
+1.200
PASW
0.6183
+33.95%
+0.157
View More